3 Top Biotech Stocks to Watch in July
Between erratic market conditions, risk-fraught clinical trials, and unpredictable drug development pipelines, biotech investors know that with some stocks, discretion is the better part of valor. Nonetheless, July is a critical month for several leading biotech companies, and there's a lot that investors need to know if they want to make a prudent decision about whether to invest.
As one of the first biotech companies to move into clinical trials with a COVID-19 vaccine candidate, Moderna (NASDAQ: MRNA) has had a rollercoaster of a year, with its stock growing in the triple digits from March to May. But Moderna's shares stumbled immediately after the company announced at the end of June that its highly anticipated COVID-19 vaccine phase 3 clinical trials had been delayed for an unknown period. The delay is related to Moderna's dosing protocol, but it's unclear if it means that the company's phase 2 results were worse than expected.
Image Source: Getty Images.
Source Fool.com
